Peyton Greenside is the co-founder and CEO of BigHat Biosciences, a Bay Area biotechnology company pioneering an ML-driven platform to accelerate the design of next-generation antibodies and other therapeutic proteins. She holds a PhD from Stanford University, an MPhil in Computational Biology from the University of Cambridge, and a BA in Applied Mathematics from Harvard.